CVS HEALTH CORP (CVS.DE) Stock Price, Quote, News and Overview
FRA:CVS - Deutsche Boerse Ag - US1266501006 - Common Stock - Currency: EUR
CVS.DE Quote, Performance and Key Statistics
FRA:CVS (4/23/2025, 7:00:00 PM)
57.56
+0.37 (+0.65%)
The current stock price of CVS.DE is 57.56 EUR. In the past month the price decreased by -9.13%. In the past year, price decreased by -8.36%.
CVS.DE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FME.DE | FRESENIUS MEDICAL CARE AG | 13.14 | 25.06B | ||
| FRE.DE | FRESENIUS SE & CO KGAA | 13.27 | 22.49B | ||
| V3V.DE | FAMICORD AG | 29 | 71.62M |
Related stock screener links
About CVS.DE
Company Profile
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. The company is headquartered in Woonsocket, Rhode Island and currently employs 300,000 full-time employees. The firm's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.
Company Info
CVS HEALTH CORP
1 Cvs Dr
Woonsocket RHODE ISLAND US
Employees: 259500
Company Website: https://cvshealth.com/
Investor Relations: https://investors.cvshealth.com
Phone: 14017651500
CVS HEALTH CORP / CVS.DE FAQ
What is the stock price of CVS HEALTH CORP today?
The current stock price of CVS.DE is 57.56 EUR. The price increased by 0.65% in the last trading session.
What is the ticker symbol for CVS HEALTH CORP stock?
The exchange symbol of CVS HEALTH CORP is CVS and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is CVS.DE stock listed?
CVS.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for CVS HEALTH CORP stock?
33 analysts have analysed CVS.DE and the average price target is 67.06 EUR. This implies a price increase of 16.51% is expected in the next year compared to the current price of 57.56. Check the CVS HEALTH CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CVS HEALTH CORP worth?
CVS HEALTH CORP (CVS.DE) has a market capitalization of 72.66B EUR. This makes CVS.DE a Large Cap stock.
How many employees does CVS HEALTH CORP have?
CVS HEALTH CORP (CVS.DE) currently has 259500 employees.
What are the support and resistance levels for CVS HEALTH CORP (CVS.DE) stock?
CVS HEALTH CORP (CVS.DE) has a support level at 57.55 and a resistance level at 60.41. Check the full technical report for a detailed analysis of CVS.DE support and resistance levels.
Is CVS HEALTH CORP (CVS.DE) expected to grow?
The Revenue of CVS HEALTH CORP (CVS.DE) is expected to grow by 4.67% in the next year. Check the estimates tab for more information on the CVS.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CVS HEALTH CORP (CVS.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CVS.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CVS.DE, evaluating the profitability, health, valuation and growth aspects
- CVS HEALTH CORP (CVS.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CVS HEALTH CORP (CVS.DE) Sales and EPS estimates to see what analysts future expectations are.
- CVS HEALTH CORP (CVS.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CVS HEALTH CORP (CVS.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- CVS HEALTH CORP (CVS.DE) Stock Chart to make your own analysis
- CVS HEALTH CORP (CVS.DE) Latest news and press-releases to stay up to date.
Does CVS HEALTH CORP (CVS.DE) stock pay dividends?
CVS HEALTH CORP (CVS.DE) has a dividend yield of 3.95%. The yearly dividend amount is currently 2.33. Check the full fundamental report for a detailed analysis of CVS.DE dividend history, reliability and sustainability.
When does CVS HEALTH CORP (CVS.DE) report earnings?
CVS HEALTH CORP (CVS.DE) will report earnings on 2025-05-01, before the market open.
What is the Price/Earnings (PE) ratio of CVS HEALTH CORP (CVS.DE)?
The PE ratio for CVS HEALTH CORP (CVS.DE) is 12.12. This is based on the reported non-GAAP earnings per share of 4.75 and the current share price of 57.56 EUR. Check the full fundamental report for a full analysis of the valuation metrics for CVS.DE.
CVS.DE Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to CVS.DE. When comparing the yearly performance of all stocks, CVS.DE turns out to be only a medium performer in the overall market: it outperformed 67.15% of all stocks.
CVS.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CVS.DE. While CVS.DE is still in line with the averages on profitability rating, there are concerns on its financial health.
CVS.DE Financial Highlights
Over the last trailing twelve months CVS.DE reported a non-GAAP Earnings per Share(EPS) of 4.75. The EPS decreased by -37.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.24% | ||
| ROA | 1.82% | ||
| ROE | 6.11% | ||
| Debt/Equity | 0.83 |
CVS.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 76% to CVS.DE. The Buy consensus is the average rating of analysts ratings from 33 analysts.
For the next year, analysts expect an EPS growth of 10.02% and a revenue growth 4.67% for CVS.DE